Wait, what? Oracle tech founder Larry Ellison invests into ex-stealth genomics diagnostics biotech

The co-founder, ex-CEO and now CTO of tech giant Oracle Corporation co-led an $18.5 million Series A into Imagene AI, an oncology-focused biotech looking to integrate its custom algorithms into digitized genomics and predict certain aspects of someone’s cancer, such as response to certain therapies and the presence of certain mutations.